search
Back to results

The Effect of Liposome Vitamin C on the Absorption and Metabolism of the Human Body.

Primary Purpose

Vitamin C Deficiency

Status
Completed
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
vitamin C without liposome
liposomal process A vitamin C
liposomal process B vitamin C (Double Nutri™)
Sponsored by
TCI Co., Ltd.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Vitamin C Deficiency

Eligibility Criteria

20 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Adults between 20-60 years old,
  2. No heart, liver, kidney, endocrine and major organic diseases

Exclusion Criteria:

  1. Renal insufficiency and dialysis
  2. Cancer
  3. Underweight (BMI≦17) or obese (BMI≧27),
  4. Take chronic disease drugs,
  5. Blood pressure systolic blood pressure ≧130 mmHg or diastolic blood pressure ≧85 mmHg,
  6. Too high fasting blood glucose ≧ 100 mg/dL,
  7. Triglyceride ≧ 150 mg/dL,Total cholesterol ≧ 200 mg/dL,
  8. Have a history of vitamin C allergy,
  9. People with mental illness,
  10. Pregnant or breastfeeding women,
  11. Hematosis,
  12. Kidney stones,
  13. Long-term vitamin C supplements (at least 200 mg per day for more than one month)

Sites / Locations

  • Research & Design Center, TCI CO., Ltd

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Sham Comparator

Placebo Comparator

Experimental

Arm Label

vitamin C without liposome

liposomal process A vitamin C

liposomal process B vitamin C (Double Nutri™)

Arm Description

vitamin C without liposome

liposomal process A vitamin C

liposomal process B vitamin C (Double Nutri™)

Outcomes

Primary Outcome Measures

vitamin c detection
vitamin c was assessed by Ascorbic Acid Colorimetric Assay Kit II
The change of Triglyceride
Venous blood was sampled to measure concentrations of Triglyceride
The change of body mass index (BMI)
BMI is a measurement of a person's leanness or corpulence based on their height and weight, and is intended to quantify tissue mass.The body mass index (BMI, kg/m^2) and body mass (kg) were assessed by InBody770.
The change of aspartate aminotransferase
Venous blood was sampled to measure concentrations of aspartate aminotransferase
The change of alanine aminotransferase
Venous blood was sampled to measure concentrations of alanine aminotransferase
The change of creatine
Venous blood was sampled to measure concentrations of creatine

Secondary Outcome Measures

Full Information

First Posted
May 9, 2021
Last Updated
May 13, 2021
Sponsor
TCI Co., Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT04886752
Brief Title
The Effect of Liposome Vitamin C on the Absorption and Metabolism of the Human Body.
Official Title
The Effect of Liposome Vitamin C on the Absorption
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
June 10, 2019 (Actual)
Primary Completion Date
June 9, 2020 (Actual)
Study Completion Date
December 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
TCI Co., Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To evaluate the difference between vitamin C in the form of oral liposomes and general vitamin C in a fixed period of time in plasma and urine.
Detailed Description
we recruited 11 healthy subjects and adopted a cross-over test. the subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start. The subjects were informed to consume one sachet vitamin C without liposome, liposomal process A vitamin C, or liposomal process B vitamin C (Double Nutri™) every test, and vitamin C concentration was measured at baseline (0 hours), 0.5, 1, 2, 3, 4, and 8 hours after taking test sample.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vitamin C Deficiency

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
11 (Actual)

8. Arms, Groups, and Interventions

Arm Title
vitamin C without liposome
Arm Type
Sham Comparator
Arm Description
vitamin C without liposome
Arm Title
liposomal process A vitamin C
Arm Type
Placebo Comparator
Arm Description
liposomal process A vitamin C
Arm Title
liposomal process B vitamin C (Double Nutri™)
Arm Type
Experimental
Arm Description
liposomal process B vitamin C (Double Nutri™)
Intervention Type
Dietary Supplement
Intervention Name(s)
vitamin C without liposome
Intervention Description
subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start
Intervention Type
Dietary Supplement
Intervention Name(s)
liposomal process A vitamin C
Intervention Description
subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start
Intervention Type
Dietary Supplement
Intervention Name(s)
liposomal process B vitamin C (Double Nutri™)
Intervention Description
subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start
Primary Outcome Measure Information:
Title
vitamin c detection
Description
vitamin c was assessed by Ascorbic Acid Colorimetric Assay Kit II
Time Frame
at 8 hours after taking test sample
Title
The change of Triglyceride
Description
Venous blood was sampled to measure concentrations of Triglyceride
Time Frame
at 8 hours after taking test sample
Title
The change of body mass index (BMI)
Description
BMI is a measurement of a person's leanness or corpulence based on their height and weight, and is intended to quantify tissue mass.The body mass index (BMI, kg/m^2) and body mass (kg) were assessed by InBody770.
Time Frame
Time 0, 0.5, 1, 2, 3, 4, and 8 hours after taking test sample
Title
The change of aspartate aminotransferase
Description
Venous blood was sampled to measure concentrations of aspartate aminotransferase
Time Frame
at 8 hours after taking test sample
Title
The change of alanine aminotransferase
Description
Venous blood was sampled to measure concentrations of alanine aminotransferase
Time Frame
at 8 hours after taking test sample
Title
The change of creatine
Description
Venous blood was sampled to measure concentrations of creatine
Time Frame
at 8 hours after taking test sample

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adults between 20-60 years old, No heart, liver, kidney, endocrine and major organic diseases Exclusion Criteria: Renal insufficiency and dialysis Cancer Underweight (BMI≦17) or obese (BMI≧27), Take chronic disease drugs, Blood pressure systolic blood pressure ≧130 mmHg or diastolic blood pressure ≧85 mmHg, Too high fasting blood glucose ≧ 100 mg/dL, Triglyceride ≧ 150 mg/dL,Total cholesterol ≧ 200 mg/dL, Have a history of vitamin C allergy, People with mental illness, Pregnant or breastfeeding women, Hematosis, Kidney stones, Long-term vitamin C supplements (at least 200 mg per day for more than one month)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jaw-Shiun Tsai, Doctor
Organizational Affiliation
National Taiwan University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Research & Design Center, TCI CO., Ltd
City
Taipei
ZIP/Postal Code
114
Country
Taiwan

12. IPD Sharing Statement

Learn more about this trial

The Effect of Liposome Vitamin C on the Absorption and Metabolism of the Human Body.

We'll reach out to this number within 24 hrs